Condition

MRD clinical trials and research

• 6Clinical trials
• 1Country

Newest MRD clinical trials

All recruiting trials (6)

• How well minimal residual disease is cleared in AL amyloidosis after first-line Dara-BorCyD

  This study tests whether achieving very good partial or complete marrow responses with Dara-BorCyD and planned stem cell transplant helps AL amyloidosis patients, by looking at minimal residual disease after treatment.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07215494

• Adaptive adjuvant sintilimab treatment guided by MRD for resected Stage II–IIIB NSCLC

  This trial tests whether using postoperative blood MRD tests to guide adjuvant sintilimab helps people with resected Stage II–IIIB NSCLC who did not achieve a complete response after neoadjuvant chemo‑immunotherapy.

  Recruiting at 2 sites Phase 2 Guangdong Association of Clinical Trials · Guangzhou, Guangdong and 1 other locations · NCT07120698

• Observing MRD's role in local treatment for oligometastatic breast cancer

  This study is trying to see if measuring minimal residual disease (MRD) can help doctors figure out which patients with oligometastatic breast cancer will do better after local treatment.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT06918262

• MRD-guided treatment for high-risk newly diagnosed multiple myeloma

  This treatment will test whether combining daratumumab, carfilzomib, lenalidomide and dexamethasone, with or without autologous stem‑cell transplant and MRD‑guided maintenance, can keep high‑risk newly diagnosed multiple myeloma patients free of measurable disease for one year.

  Recruiting Phase 4 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06409702

• Adaptive treatment for acute myeloid leukemia based on early results

  This study is testing a new treatment plan for people with untreated acute myeloid leukemia to see if adding a drug called selinexor helps those who still have cancer after two weeks of initial therapy.

  Recruiting Phase 2 Shanghai Tong Ren Hospital · Shanghai and 3 other locations · NCT05736978

• Adjuvant treatment for EGFR mutant non-small cell lung cancer based on MRD status

  This study is testing if a specific cancer treatment can help people with a certain type of lung cancer after surgery, based on whether they have leftover cancer cells in their body.

  Recruiting Phase 2 Guangdong Association of Clinical Trials · Beijing and 15 other locations · NCT05536505

Related topics

Quick answers

How many MRD clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →